Frost edit · Free shipping over $70 · Cool essentials

Login Register

glutathione colorimetric assay kit Reduced (GSH) Colorime Elisa at ₹ 18000/kit | Elisa Kits in New Delhi The product Total Glutathione (T-GSH)/Oxidized Glutathione Colorimetric

glutathione colorimetric assay kit

glutathione colorimetric assay kit Reduced (GSH) Colorime Elisa at ₹ 18000/kit | Elisa Kits in New Delhi The product Total Glutathione (T-GSH)/Oxidized Glutathione Colorimetric

SKU: 76510315515

4.1

USD28.94 USD63.94

Pay in 4 interest-free payments of $7.24 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

An anti-inflammatory activation sequence governs macrophage transcriptional dynamics during tissue injury in zebrafish

glutathione colorimetric assay kit Reduced (GSH) Colorime Elisa at 18000/kit | Elisa Kits in New Delhi The product Total Glutathione (T-GSH)/Oxidized Glutathione Colorimetric

Disruption of proteostasis is now recognized as a unifying pathological hallmark linking neurodegenerative disorders, cancer, cardiovascular and metabolic diseases, and autoimmune conditions

glutathione colorimetric assay kit Reduced (GSH) Colorime Elisa at 18000/kit | Elisa Kits in New Delhi The product Total Glutathione (T-GSH)/Oxidized Glutathione Colorimetric

Curr Res Immunol

glutathione colorimetric assay kit Reduced (GSH) Colorime Elisa at 18000/kit | Elisa Kits in New Delhi The product Total Glutathione (T-GSH)/Oxidized Glutathione Colorimetric

Research applications include HGF/MET receptor pathway studies, synaptic signalling research, and comparative angiotensin analogue pharmacology

glutathione colorimetric assay kit Reduced (GSH) Colorime Elisa at 18000/kit | Elisa Kits in New Delhi The product Total Glutathione (T-GSH)/Oxidized Glutathione Colorimetric

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

The power of three: Retatrutide's role in modern obesity and diabetes therapy

The power of three: Retatrutide's role in modern obesity and diabetes therapy

US$ 25.54

4.5 (19 reviews)

Diagram showing the mechanism of action of retatrutide

Diagram showing the mechanism of action of retatrutide

US$ 28.72

4.4 (12 reviews)

Frontiers

Frontiers

US$ 29.02

4.8 (13 reviews)

First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the

First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the

US$ 23.49

4.1 (12 reviews)

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor

US$ 22.09

4.1 (28 reviews)

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

US$ 23.88

4.0 (22 reviews)

How Retatrutide works: mechanism of action and onset explained

How Retatrutide works: mechanism of action and onset explained

US$ 27.95

5.0 (18 reviews)

💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with type 2 diabetes, a new phase 3 trial shows. Retatrutide is part of an emerging generation

💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with type 2 diabetes, a new phase 3 trial shows. Retatrutide is part of an emerging generation

US$ 28.02

4.6 (10 reviews)

🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market. This triple receptor agonist (GIP/ GLP-1/glucagon) is showing unprecedented results in weight loss trials, outperforming current

🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market. This triple receptor agonist (GIP/ GLP-1/glucagon) is showing unprecedented results in weight loss trials, outperforming current

US$ 22.08

4.7 (30 reviews)

What is the pipeline for future medications for obesity?

What is the pipeline for future medications for obesity?

US$ 22.32

4.0 (14 reviews)

𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong

𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong

US$ 28.41

4.9 (16 reviews)

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome

US$ 22.87

4.2 (23 reviews)

Retatrutide Research Guide: What the Phase 2 Trial Data Reported (2026)

Retatrutide Research Guide: What the Phase 2 Trial Data Reported (2026)

US$ 27.19

4.6 (8 reviews)

Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders

Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders

US$ 29.83

4.9 (22 reviews)

Frontiers

Frontiers

US$ 21.07

4.8 (27 reviews)

Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care

Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care

US$ 26.36

4.9 (27 reviews)

Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity

Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity

US$ 27.18

4.6 (22 reviews)

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide

US$ 29.07

5.0 (18 reviews)

Next generation dual GLP-1/GIP, GLP-1/glucagon, and triple GLP-1/GIP/glucagon agonists: a literature review

Next generation dual GLP-1/GIP, GLP-1/glucagon, and triple GLP-1/GIP/glucagon agonists: a literature review

US$ 29.77

4.9 (8 reviews)

Effects, working principles and target tissues of dual agonists

Effects, working principles and target tissues of dual agonists

US$ 24.87

4.9 (7 reviews)